T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Nature Medicine

Topics

Biology

Biochemistry

Medicine

Cancer Oncology

Immunology

Show all topics

DOI

10.1038/s41591-020-01194-5